cyclosporine has been researched along with Cutaneous T-Cell Lymphoma in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, J; Guitart, J; Kaplan, JB; Lee, DE; Martinez-Escala, ME; Pro, B; Serrano, LM; Zhou, XA | 1 |
| Abramson, AK; Day, A; Menter, MA; Patel, M; Warren, RB | 1 |
| Chen, CC; Teng, CL; Yeh, SP | 1 |
| Al Robaee, A; Al Shobaili, HA; Alfawzan, S; Alzolibani, AA; Assaf, C; Assanasen, T; Feldman, AL; Goodlad, JR; Groves, MJ; Hummel, M; Kernohan, N; Kini, H; Maccallum, S; Marschalkó, M; Robson, A; Rojnuckarin, P; Sterry, W; Tauro, S | 1 |
| Campbell, LS; Geskin, LJ; Jukic, DM; Pomerantz, RG | 1 |
| Brocard, A; Dréno, B; Knol, AC; Peuvrel, L; Quéreux, G; Renaut, JJ | 1 |
| Blewitt, RW; Kirby, B; Owen, CM; Yates, VM | 1 |
| Altieri, E; Corazza, M; Montanari, A; Virgili, A; Zampino, MR | 1 |
| Huang, FS; Lucky, AW; Murphy, S; Paller, AS; Passo, M; Prendiville, J; Shani-Adir, A | 1 |
| Balme, B; Dalle, S; Houot, R; Mougel, F; Thomas, L | 1 |
| Assanasen, T; Intragumtornchai, T; Nakorn, TN; Rojnuckarin, P; Wannakrairot, P | 1 |
| Braverman, IM; Cooper, DL; Davis, CA; Durivage, HJ; Hait, WN; Saidman, BH; Sarris, AH | 1 |
| Kadin, ME; Nowak, I; Nowell, PC; Rook, AH; Shaw, LM; Vonderheid, EC; Wasik, MA; Zhang, Q | 1 |
3 review(s) available for cyclosporine and Cutaneous T-Cell Lymphoma
| Article | Year |
|---|---|
The spectrum of oculocutaneous disease: Part II. Neoplastic and drug-related causes of oculocutaneous disease.
Topics: Aortic Coarctation; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Comorbidity; Cyclosporine; Dermatologic Agents; Eye Abnormalities; Eye Diseases; Eyelid Neoplasms; Humans; Lymphoma, T-Cell, Cutaneous; Melanoma; Mohs Surgery; Multiple Myeloma; Neurocutaneous Syndromes; Retinoids; Sebaceous Gland Neoplasms; Skin Diseases; Skin Neoplasms; Stevens-Johnson Syndrome; Syndrome; Tumor Necrosis Factor-alpha | 2014 |
Relapsed and refractory subcutaneous panniculitis-like T-cell lymphoma with excellent response to cyclosporine: a case report and literature review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclosporine; Cytarabine; Deoxycytidine; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Gemcitabine; Humans; Immunosuppressive Agents; Lymphoma, T-Cell, Cutaneous; Male; Methylprednisolone; Multimodal Imaging; Panniculitis; Positron-Emission Tomography; Recurrence; Remission Induction; Salvage Therapy; Skin Neoplasms; Subcutaneous Fat; Tomography, X-Ray Computed | 2016 |
Subcutaneous panniculitic T-cell lymphoma in children: response to combination therapy with cyclosporine and chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclosporine; Diagnosis, Differential; Extremities; Face; Humans; Immunosuppressive Agents; Lymphoma, T-Cell, Cutaneous; Male; Panniculitis; Skin Neoplasms | 2004 |
1 trial(s) available for cyclosporine and Cutaneous T-Cell Lymphoma
| Article | Year |
|---|---|
Cyclosporine treatment of refractory T-cell lymphomas.
Topics: Adult; Aged; Cyclosporine; Female; Humans; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Male; Middle Aged | 1993 |
9 other study(ies) available for cyclosporine and Cutaneous T-Cell Lymphoma
| Article | Year |
|---|---|
Hemophagocytic Lymphohistiocytosis in Cutaneous T-Cell Lymphoma.
Topics: Adrenal Cortex Hormones; Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Skin Neoplasms | 2018 |
Immunohistochemical localization of cellular NFATc1 does not predict clinical responses to ciclosporin in subcutaneous panniculitis-like T-cell non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; NFATC Transcription Factors; Panniculitis; Young Adult | 2010 |
Posttransplant cutaneous T-cell lymphoma: case reports and review of the association of calcineurin inhibitor use with posttransplant lymphoproliferative disease risk.
Topics: Adult; Aged; Calcineurin Inhibitors; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoma, T-Cell, Cutaneous; Male; Risk Factors; Sex Factors; Skin Neoplasms; Tacrolimus | 2010 |
Sudden onset of an aggressive cutaneous lymphoma in a young patient with psoriasis: role of immunosuppressants.
Topics: Adult; Antibiotics, Antineoplastic; Biopsy; Cyclosporine; Doxorubicin; Etanercept; Fatal Outcome; Humans; Immunoglobulin G; Immunosuppressive Agents; Leg; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Neoplasm Invasiveness; Neoplasm Staging; Polyethylene Glycols; Psoriasis; Receptors, Tumor Necrosis Factor; Skin Neoplasms; Treatment Failure | 2010 |
Cutaneous T-cell lymphoma developing in a patient on cyclosporin therapy.
Topics: Adult; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Humans; Lymphoma, T-Cell, Cutaneous; Male; Skin Neoplasms | 2002 |
Primary cutaneous CD30+ large T-cell lymphoma in a patient with psoriasis treated with cyclosporine.
Topics: Biomarkers, Tumor; Cyclosporine; Etretinate; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Keratolytic Agents; Ki-1 Antigen; Lymphoma, T-Cell, Cutaneous; Middle Aged; Psoriasis; Risk Factors; Skin Neoplasms | 2003 |
Aggressive CD30 large cell lymphoma after cyclosporine given for putative atopic dermatitis.
Topics: Adult; Cyclosporine; Dermatitis, Atopic; Humans; Immunosuppressive Agents; Ki-1 Antigen; Lymphoma, T-Cell, Cutaneous; Male; Skin Neoplasms | 2006 |
Cyclosporin in subcutaneous panniculitis-like T-cell lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cyclosporine; Cytarabine; Doxorubicin; Etoposide; Female; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Humans; Immunosuppressive Agents; Lymphoma, T-Cell, Cutaneous; Male; Methylprednisolone; Middle Aged; Panniculitis; Prednisone; Prognosis; Remission Induction; Skin Neoplasms; Treatment Outcome; Vincristine | 2007 |
Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
Topics: Cell Membrane; Cyclosporine; DNA-Binding Proteins; Humans; Immunosuppressive Agents; Janus Kinase 3; Lymphocyte Activation; Lymphoma, T-Cell, Cutaneous; Milk Proteins; Phosphorylation; Polyenes; Prednisone; Protein Binding; Protein-Tyrosine Kinases; Receptors, Interleukin-2; Sezary Syndrome; Signal Transduction; Sirolimus; STAT3 Transcription Factor; STAT5 Transcription Factor; Tacrolimus; Trans-Activators; Tumor Cells, Cultured | 1996 |